Ortin Laboratories Ltd - 539287 - Closure of Trading Window
Closure of trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 for the quarter ended 30.06.202429-06-2024
29-06-2024
Ortin Laboratories Ltd - 539287 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Announcement under Regulation 30 of SEBI (LODR) Regulations, 201530-05-2024
Ortin Laboratories Ltd - 539287 - Audited Financial Results For The Quarter And Financial Year Ended 31.03.2024
Audited financial results for the quarter and financial year ended 31.03.202430-05-2024
Ortin Laboratories Ltd - 539287 - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Year Ended 31.03.2024 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Outcome of Board Meeting for the quarter and year ended 31.03.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015.30-05-2024
Ortin Laboratories Ltd - 539287 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31.03.202430-05-2024
Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Audited Results For The Quarter And Year Ended 31.03.2024
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. Audited Financial Statements for the quarter and year ended 31.03.2024. 2. Audit Report for the year ended 31.03.2024. 3. Any other business with the permission of the Chair.22-05-2024
Ortin Laboratories Ltd - 539287 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Ortin Laboratories Ltd 2 CIN NO. L24110TG1986PLC006885 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2024-25, FY 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2023-24,2022-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Divya PurswaniDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Srinivasa Kumar Sanka Designation : -CFO Date: 20/04/202420-04-2024
Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg.74 (5) of SEBI (DP) Regulations ,2018 for the Quarter and year ended 31.03.202417-04-2024
Ortin Laboratories Ltd - 539287 - Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The FY Ending 31.03.2024
Disclosure under regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements ) Regulations, 2015 for the FY ending 31.03.202417-04-2024
Ortin Laboratories Ltd - 539287 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31.03.2024.
Compliance certificate under regulation 7(3)of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31.03.202417-04-2024